Home  »  Markets   »  Here is a breakdown of major shareholders in Lumin...

Here is a breakdown of major shareholders in Luminex Corporation (NASDAQ: LMNX)

296 institutions hold shares in Luminex Corporation (LMNX), with 2.08M shares held by insiders accounting for 4.45% while institutional investors hold 96.29% of the company’s shares. The shares outstanding are 45.65M, and float is at 44.24M with Short Float at 5.38%. Institutions hold 92.00% of the Float.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Blackrock Inc. with over 8.16 million shares valued at $188.75 million. The investor’s holdings represent 17.26% of the LMNX Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 5.23 million shares valued at $120.89 million to account for 11.05% of the shares outstanding. The other top investors are RGM Capital, LLC which holds 2.7 million shares representing 5.71% and valued at over $62.5 million, while Dimensional Fund Advisors LP holds 3.90% of the shares totaling 1.84 million with a market value of $42.6 million.

Luminex Corporation (NASDAQ: LMNX) is 58.65% higher on its value in year-to-date trading and has touched a low of $20.61 and a high of $41.69 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LMNX stock was last observed hovering at around $36.82 in the last trading session, with the day’s loss setting it -0.14% off its average median price target of $37.00 for the next 12 months. It is also 0.86% off the consensus price target high of $37.00 offered by 5 analysts, but current levels are -14.63% lower than the price target low of $32.00 for the same period.

Currently trading at $36.68, the stock is 4.89% and 11.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.96 million and changing -0.38% at the moment leaves the stock 29.47% off its SMA200. LMNX registered 4.59% gain for a year compared to 6-month gain of 67.57%. The firm has a 50-day simple moving average (SMA 50) of $33.98 and a 200-day simple moving average (SMA200) of $27.59.

The stock witnessed a 17.00% loss in the last 1 month and extending the period to 3 months gives it a 32.56%, and is -0.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.51% over the week and 1.91% over the month.

Luminex Corporation (LMNX) has around 1325 employees, a market worth around $1.70B and $417.40M in sales. Current P/E ratio is 113.56 and Fwd P/E is 33.65. Profit margin for the company is 3.60%. Distance from 52-week low is 77.97% and -12.02% from its 52-week high. The company has generated returns on investments over the last 12 months (4.00%).

Luminex Corporation (LMNX) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Luminex Corporation (LMNX) is a “Hold”. 5 analysts offering their recommendations for the stock have an average rating of 3.00, where 5 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Luminex Corporation is expected to release its quarterly report on 08/09/2021 and quarterly earnings per share for the current quarter are estimated at $0.14 with sales reaching $109.53M over the same period.The EPS is expected to grow by 238.20% this year, but quarterly earnings will post 15.00% year-over-year. Quarterly sales are estimated to grow 21.10% in year-over-year returns.

Luminex Corporation (LMNX) Insider Activity

A total of 31 insider transactions have happened at Luminex Corporation (LMNX) in the last six months, with sales accounting for 13 and purchases happening 18 times. The most recent transaction is an insider sale by CURRIE HARRISS T, the company’s SVP, Finance & CFO. SEC filings show that CURRIE HARRISS T sold 5,325 shares of the company’s common stock on Mar 01 at a price of $32.35 per share for a total of $0.17 million. Following the sale, the insider now owns 0.23 million shares.

Luminex Corporation disclosed in a document filed with the SEC on Feb 25 that Bennett Todd C. (SVP, Global Sales & Cust Ops) sold a total of 121,507 shares of the company’s common stock. The trade occurred on Feb 25 and was made at $34.06 per share for $4.14 million. Following the transaction, the insider now directly holds 34197.0 shares of the LMNX stock.

Still, SEC filings show that on Nov 25, Eck Stephen L. (Director) acquired 4,487 shares at an average price of $22.40 for $0.1 million. The insider now directly holds 37,807 shares of Luminex Corporation (LMNX).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Luminex Corporation (LMNX): Who are the competitors?

The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading 46.12% up over the past 12 months. Hologic Inc. (HOLX) is 48.71% up on the 1-year trading charts. Short interest in the company’s stock has risen 21.71% from the last report on Apr 14, 2021 to stand at a total of 2.38 million short shares sold with a short interest ratio of 1.51.

Related Posts

110500

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam